Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay
IRCCS Policlinico S. Donato
80 participants
Sep 30, 2025
INTERVENTIONAL
Conditions
Summary
MANCAVA sets out fundamental methodologies for characterizing human fundamental physiological system interactions at a whole-body level, particularly focusing on the interplay among cortical brain activity, autonomic function, and cerebrovascular autoregulatory mechanisms. By investigating the complex, time-varying mechanisms underlying the multisystem dynamic interactions, novel methods linking various brain areas and reflex functions to target organs and districts such as heart and circulatory system are proposed with the clinical aim linked to the emerging topic of depression. In this scenario, proper new mathematical tools will allow a significant leap from the current state of the art, paving the way towards a new understanding of leading comorbid contributors to global diseases such as cardiac and cerebrovascular morbidity in mood disorders. In turn, this will provide an integration among physiological and psychological dimensions for a more holistic view on depression. Researchers, professionals, and patients will all benefit from a comprehensive assessment of brain-mind-body interplay, leading to the new extended definition of default mode/mood network, neurovascular-evoked responses to autonomic stimuli, brain-autonomic consequences of emotional responses, and physiological substrates of depressive states.
Eligibility
Inclusion Criteria4
- age older than 18 years
- spontaneous sinus rhythm
- signed informed consent
- indication to heart surgery
Exclusion Criteria4
- age lower than 18 years
- absence of sinus rhythm
- pregnancy
- impossibility of informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
From a clinical perspective, MANCAVA will especially target neuro-cardiovascular health and mood disorders such as depression
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06294119